Akynzeo 300mg/0.5mg Capsule
By Akynzeo
Rx
1 Capsule in a Strip

Composition
Netupitant(300mg) + Palonosetron(0.5mg)

Manufacturer - Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.

Expires on or after
October, 2025

liver
Akynzeo 300mg/0.5mg Capsule may not be safe for individuals with liver disease, and it is recommended to avoid using this medication in such cases. It is crucial to seek advice from your healthcare provider before considering the use of Akynzeo to ensure your safety and well-being.

kidney
Akynzeo 300mg/0.5mg Capsule may not be safe for patients with kidney disease and should be avoided. Kindly consult your doctor before use.

alcohol
Consult your doctor when consuming alcohol with Akynzeo 300mg/0.5mg Capsule.

driving
Akynzeo 300mg/0.5mg Capsule may reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Akynzeo 300mg/0.5mg Capsule may not be safe during pregnancy. Animal studies suggest potential harm to the developing baby. Consult your doctor for weighing the benefits and risks before use.

breastfeeding
It is better to consult your doctor before using Akynzeo 300mg/0.5mg Capsule.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | - |
₹6000
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025